- Industry Symposium
Evolving the Clinical Utility of dd-cfDNA (AlloSure/AlloSeq cfDNA) in Organ Transplantation

Wednesday September 14, 2022 | 13:15 to 14:15
Room: A
Track: N/A

Organized by CareDx


Description

This activity is not EACCME accredited

Presentations

Tarek Alhamad, United States
Clinical utility of dd-cfDNA in kidney transplant surveillance

Helio Tedesco Silva Jr, Brazil
Clinical Utility of dd-cfDNA in Delayed Graft Function

Dr. Robert Montgomery, United States
Xenotransplantation: the NYU experience and the potential of dd-cfDNA as a biomarker for surveillance

Prof. Alexandre Loupy, France
Using AI to Enhance the Predictive Capability of dd-cfDNA (AlloSure)



© 2024 TTS 2022